An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.

• Status: Completed
• Trial end date: 2016-07-01

Summary

The purpose of this study is to compare of difference in NRS scores from baseline to the completion of treatment (5 days) in patients with administration of morphine sulfate versus oxycodone hydrochloride.

• Phase: Phase 4

Details

• Lead Sponsor: Mundipharma Korea Ltd
• Treatments: Morphine; Oxycodone